Behzad Aghazadeh

Director, 10% Owner, Other; Director, Other · 4 filings · Latest: Jul 24, 2026

Scribe Therapeutics, Inc.

Whitehawk Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SCTX	Behzad Aghazadeh	Director, 10% Owner, Other	Jul 28, 2026	Purchase	$18.25	7,905	$144.3K	3,088,888	Jul 29 1:30 AM
SCTX	Behzad Aghazadeh	Director, 10% Owner, Other	Jul 24, 2026	Purchase	$15.15	2,383,333	$36.1M	3,080,983	Jul 29 1:30 AM